Hsiaopei Mok
Overview
Explore the profile of Hsiaopei Mok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li K, Cao L, Li C, Wu J, Chen B, Zhang G, et al.
Cancer Med
. 2022 Nov;
12(5):5195-5208.
PMID: 36404592
Backgroud: There were limitations existing in programmed cell-death ligand 1 (PD-L1) as predictive biomarkers for breast cancer (BC), hence exploring the correlation between PD-L1 levels and other biomarkers in BC...
2.
Liao N, Li C, Cao L, Chen Y, Ren C, Chen X, et al.
Breast Cancer
. 2022 Sep;
30(1):77-87.
PMID: 36129636
Purpose: Little is known about the host-tumor interaction in the lymph-node basin at a single cell level. This study examines single cell sequences in breast cancer nodal metastases of a...
3.
Zhang G, Ren C, Li C, Wang Y, Chen B, Wen L, et al.
BMC Med
. 2022 Apr;
20(1):142.
PMID: 35484593
Background: HER2-low breast cancers were reported to have distinct clinicopathological characteristics from HER2-zero; however, the difference in their genetic features remains unclear. This study investigated the clinical and molecular features...
4.
Cao L, Ren C, Zhang G, Li X, Chen B, Li K, et al.
DNA Cell Biol
. 2022 Apr;
41(5):521-538.
PMID: 35475703
amplification is detected in ∼15% of breast tumors and is associated with poor prognosis by mediating acquired resistance to anticancer therapies. This study aimed to determine the prevalence of amplifications...
5.
Li Y, Chen B, Lin X, Zhang G, Lai J, Li C, et al.
Front Oncol
. 2022 Apr;
12:830124.
PMID: 35402236
Background: Triple-negative breast cancer (TNBC) is refractory and heterogeneous, comprising various entities with divergent phenotype, biology, and clinical presentation. As an aggressive subtype, Chinese TNBC patients with special morphologic patterns...
6.
Li C, Ren C, Wen L, Chen X, Chen B, Zhang G, et al.
Clin Med Insights Oncol
. 2022 Mar;
16:11795549211072880.
PMID: 35237089
Breast cancer is highly heterogenous with temporal and spatial heterogeneity making it necessary for rebiopsy. DS-8201a, a new potential therapy for human epidermal growth factor receptor 2 (HER2) low expression...
7.
Li C, Zhang G, Wang Y, Chen B, Li K, Cao L, et al.
Oncol Lett
. 2022 Jan;
23(2):68.
PMID: 35069877
MAP3K1 is a MAPK family serine-threonine kinase that is frequently mutated in human cancer. The association between mutations in the gene and the clinicopathological characteristics and prognosis of patients with...
8.
Lai J, Lin X, Cao F, Mok H, Chen B, Liao N
J Cell Mol Med
. 2021 Aug;
25(19):9390-9401.
PMID: 34464504
Breast cancer (BC) prognosis and therapeutic sensitivity could not be predicted efficiently. Previous evidence have shown the vital roles of CDKN1C in BC. Therefore, we aimed to construct a CDKN1C-based...
9.
Chen B, Zhang G, Lai J, Xiao W, Li X, Li C, et al.
EBioMedicine
. 2021 Aug;
71:103542.
PMID: 34454403
Background: Patients with breast cancer presenting with single lymph node metastasis (from a sentinel node) experience prolonged survival compared to patients with multiple lymph node metastases (≥3). However, little information...
10.
Chen B, Guo L, Li K, Xiao W, Li Y, Li C, et al.
Front Oncol
. 2021 Apr;
11:613933.
PMID: 33868999
Background: The relationship between body mass index (BMI) and the prognosis or treatment response in patients with breast cancer has been demonstrated in previous studies, but the somatic mutation profiles...